NPS PHARMACEUTICALS INC
DelistedCIK 890465fmd_0SNR0J2VTRB88X9FV1GKRAP2QTManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2009 to Dec 31, 2014, 20 periods
Latest annual · FY2014
Millions- Total revenues
- 224
- Gross profit
- 209
- Operating income
- 5
- Net income
- (9)
Latest quarter · Q4 FY2014
Millions- Total revenues
- 67
- Gross profit
- 60
- Operating income
- 1
- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2011 to FY2014
- +30.1%
- Revenue, 5 yearsFY2009 to FY2014
- +21.6%
- Net income, 5 yearsFY2009 to FY2014
- n/m
NPS PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Revenue | $224.1 million | $155.6 million | +44% | 10-K 2015-02-18 · proof |
| Gross profit | $209.4 million | $152 million | +37.8% | 10-K 2015-02-18 · proof |
| Operating income | $5.1 million | -$1.5 million | 10-K 2015-02-18 · proof | |
| Net income | -$8.7 million | -$13.5 million | 10-K 2015-02-18 · proof | |
| Cash from operating activities | -$16.7 million | -$24.3 million | 10-K 2015-02-18 · proof | |
| Total assets | $289.6 million | $292.2 million | -0.9% | 10-K 2015-02-18 · proof |
| Total liabilities | $155.8 million | $187.3 million | -16.8% | 10-K 2015-02-18 · proof |
| Cash and cash equivalents | $65.6 million | $51.2 million | +28% | 10-K 2015-02-18 · proof |
| Total debt | $100 million | $132.4 million | -24.5% | 10-K 2015-02-18 · proof |
- What was NPS PHARMACEUTICALS INC's revenue in fiscal 2014?
- NPS PHARMACEUTICALS INC reported revenue of $224.1 million for fiscal 2014 (the year ended Dec 31, 2014), against $155.6 million the year before (+44%). Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What was NPS PHARMACEUTICALS INC's gross profit in fiscal 2014?
- NPS PHARMACEUTICALS INC reported gross profit of $209.4 million for fiscal 2014 (the year ended Dec 31, 2014), against $152 million the year before (+37.8%). Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What was NPS PHARMACEUTICALS INC's operating income in fiscal 2014?
- NPS PHARMACEUTICALS INC reported operating income of $5.1 million for fiscal 2014 (the year ended Dec 31, 2014), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What was NPS PHARMACEUTICALS INC's net income in fiscal 2014?
- NPS PHARMACEUTICALS INC reported net income of -$8.7 million for fiscal 2014 (the year ended Dec 31, 2014), against -$13.5 million the year before. Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What was NPS PHARMACEUTICALS INC's cash from operating activities in fiscal 2014?
- NPS PHARMACEUTICALS INC reported cash from operating activities of -$16.7 million for fiscal 2014 (the year ended Dec 31, 2014), against -$24.3 million the year before. Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What are NPS PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2014, NPS PHARMACEUTICALS INC reported total assets of $289.6 million, against $292.2 million a year earlier (-0.9%). Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What are NPS PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2014, NPS PHARMACEUTICALS INC reported total liabilities of $155.8 million, against $187.3 million a year earlier (-16.8%). Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What are NPS PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2014, NPS PHARMACEUTICALS INC reported cash and cash equivalents of $65.6 million, against $51.2 million a year earlier (+28%). Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
- What is NPS PHARMACEUTICALS INC's total debt?
- As of Dec 31, 2014, NPS PHARMACEUTICALS INC reported total debt of $100 million, against $132.4 million a year earlier (-24.5%). Source: the 10-K filed with the SEC on Feb 18, 2015. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:890465&period_type=annual&limit=5"Information only, not investment advice.